Free Trial

Encompass Health Corporation $EHC Shares Sold by BDF Gestion

Encompass Health logo with Medical background

Key Points

  • BDF Gestion has reduced its holdings in Encompass Health Corporation by 9.8% in the second quarter, owning 24,610 shares valued at approximately $3,018,000 after selling 2,682 shares.
  • Encompass Health reported a 12.0% increase in revenue compared to the same quarter last year, with earnings per share (EPS) of $1.40, exceeding the consensus estimate of $1.20.
  • The company announced a quarterly dividend increase to $0.19 per share, up from the previous $0.17, reflecting a dividend yield of 0.6% and a payout ratio of 13.31%.
  • MarketBeat previews the top five stocks to own by October 1st.

BDF Gestion reduced its holdings in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 9.8% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,610 shares of the company's stock after selling 2,682 shares during the quarter. BDF Gestion's holdings in Encompass Health were worth $3,018,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently modified their holdings of the company. Exchange Traded Concepts LLC grew its position in shares of Encompass Health by 1.9% in the second quarter. Exchange Traded Concepts LLC now owns 8,095 shares of the company's stock valued at $993,000 after purchasing an additional 152 shares during the last quarter. Canandaigua National Bank & Trust Co. acquired a new stake in Encompass Health during the 2nd quarter valued at $260,000. Parallel Advisors LLC increased its position in Encompass Health by 12.2% during the second quarter. Parallel Advisors LLC now owns 2,603 shares of the company's stock worth $319,000 after buying an additional 284 shares in the last quarter. Voya Investment Management LLC increased its position in Encompass Health by 5.0% during the first quarter. Voya Investment Management LLC now owns 15,854 shares of the company's stock worth $1,606,000 after buying an additional 762 shares in the last quarter. Finally, Strs Ohio acquired a new position in shares of Encompass Health in the first quarter worth $34,364,000. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Trading Down 1.1%

Shares of EHC stock opened at $123.94 on Friday. The firm's 50-day simple moving average is $118.12 and its 200-day simple moving average is $113.61. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. Encompass Health Corporation has a 1-year low of $87.85 and a 1-year high of $127.15. The firm has a market cap of $12.48 billion, a P/E ratio of 24.25, a PEG ratio of 2.19 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The company reported $1.40 EPS for the quarter, topping the consensus estimate of $1.20 by $0.20. The firm had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. Encompass Health's revenue for the quarter was up 12.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.11 earnings per share. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. As a group, equities analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a $0.19 dividend. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. This is a boost from Encompass Health's previous quarterly dividend of $0.17. Encompass Health's payout ratio is 13.31%.

Insider Buying and Selling

In other news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the sale, the executive vice president owned 18,846 shares in the company, valued at approximately $2,329,177.14. This trade represents a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 2.00% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of analysts recently commented on EHC shares. KeyCorp increased their price objective on Encompass Health from $135.00 to $140.00 and gave the company an "overweight" rating in a research note on Tuesday. Bank of America raised their price target on shares of Encompass Health from $145.00 to $160.00 and gave the stock a "buy" rating in a research note on Wednesday, September 10th. Stephens raised shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price objective for the company in a research report on Thursday, June 5th. Truist Financial upped their price objective on shares of Encompass Health from $135.00 to $140.00 and gave the company a "buy" rating in a research note on Thursday, August 14th. Finally, Wall Street Zen cut shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. One research analyst has rated the stock with a Strong Buy rating and seven have issued a Buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $138.43.

Get Our Latest Analysis on EHC

Encompass Health Profile

(Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Featured Articles

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Encompass Health Right Now?

Before you consider Encompass Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Encompass Health wasn't on the list.

While Encompass Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.